|
Allured V. S., Collier R. J., Carroll S. F., and McKay D. B. (1986) Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 angstrom resolution. Proc. Natl Acad. Sci. USA 83, 1320-1324.
Bachmann M. F., Zinkernagel R. M. (1996) The influence of virus structure on antibody responses and virus serotype formation. Immunology Today 17, 553-558.
Danishefsky, S. J. & Allen, J. R. (2000) From the laboratory to the clinic: A retrospective on fully synthetic carbohydratebased anticancer vaccines. Angew. Chem.Intl. Eng. 39, 836–863.
Domenech N., Henderson R. A., and Finn O. J. (1995) Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J. Immunol. 155, 4766-4774.
Donnelly J. J., and Jeffrey B.U., Linda A. H., Arthur F., Xiao-Pin S., KarenR.L., John W. S., Allen I. O., Douglas M., Donna M., and Margaret A. L. (1993) Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin Proc. Natl. Acad. Sci. USA 90, 3530-3534.
Elizabeth M. H., Pawel C., and Olivera J. F. (1998) Naturally processed Class II epitope from the antigen MUC1 primes human CD4+ T cells. Cancer Research 58, 5066-5070.
Estevez F, Carr A, Solorzano L, Valiente O, Mesa C, Barroso O, Sierra G and Fernandez LE. (2000). Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP). Vaccine 18, 190-197
Feldman S. R., Rosenberg M. R., Ney K. A., Michalopoulos G., and Pizzo S. V. (1985) Binding of α 2-microglobulin to hepatocytes: mechanism of in vivo clearance. Biochem. Biophys. Res. Commun. 128, 795-802.
Foss F. M., Saleh M. N., Krueger J. G., Nichols J. C., Murphy J. R. (1998) Diphtheria toxin fusion proteins. In Clinical Applications of Immunotoxins. Edited by Frankel AE. Berlin: Springer-Verlag: 63-81.
Gendler S., Taylor-Papadimitriou J., Duhig T., Rothbard J., and Burchell J. (1988) A highly Immunogenic Region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 263, 12820-12823.
Geng, X. D., Dudkin, V. Y., Mandal, M. & Danishefsky, S. J. (2004). In pursuit of carbohydrate-based HIV vaccines, Part 2: The total synthesis of high-mannose-type gp120 fragmentsevaluation of strategies directed to maximal convergence. Angew. Chem. 43, 2562–2565
Geoffrey A. P., Wenjun L., Carla O., Vasso A., Ian F. C. M. (2000) Definition of MHC-restricted CTL epitopes from non-variable number of tandem trpeat sequence of MUC1. Vaccine 18, 2059-2071.
Hakomori, S. & Zhang, Y. (1997) Glycosphingolipid antigens and cancer therapy. Chem. Biol. 4, 97-104.
Hanisch F. G., Muller S. (2000) MUC 1: the polymorphic appearance of a human mucin. Glycobiology 10(5), 439-449.
Helling F, Shang A, Calves M et al. (1994). GD3 vaccines for melanoma: Superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Tes. 54, 197-203
Holmberg, L. & Sandmaier, B. (2004). Vaccination with Theratope (STn-KLH) as treatment for breast cancer. Espert Rev. Vaccines 3, 655-663
Hseuh K.-H., Shang H.-F., Wang L.-F., Lo, C.-K., Liao C.-W., and Hwang, J. (1994) Engineering of Pseudomonas exotoxin A into useful proteins for disease treatment. J. Chinese Biochemical Society. 23, 135-151
Hsu, C. T., Ting, C. Y., Ting, C. J., Chen, T. Y., Lin, C. P., Whang-Peng, J., and Hwang, J. (2000). Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats. Cancer Res 60, 3701-3705
Hwang J. and Chen M.-S. (1989) Structure and function relationship of Pseudomonas exotoxin A: an immunochemical study. J. Biol. Chem. 264, 2379-2384.
Hwang J., Fitzgerald D. J., Adhya S., and Pastan I. (1987) Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E.coli. Cell 48, 129-136.
Janeway C. A., Travers P., Walport M., Shlomchik M. J.: The humoral immune response. pp. 369-372, in Janeway C. A., Travers P., Walport M., Shlomchik M. J.(eds) Immunobiology, 6th edn. New York, Garland publishing, 2005.
Jones C. (2005) Vaccines based on the cell surface carbohydrates of pathogenic bacteria. An Acad Bras Cienc. 77, 293-324.
Kounnas M. Z., Morris R. E., Thompson M. R., FizFerald D. J., Strickland D. K. and Saelinger C. B. (1992) The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267, 12420-12423.
Kreitman R. J. (1999) Immunotoxins in cancer therapy. Current Opinion in Immunology 11, 570-578
Kreitman R. J., Wang Q. C., FitzGerald D. J. P., Pastan I. (1999) Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4 (dsFv)-PE38 at doses tolerated by Cynomolgus monkeys. Int. J Cancer 81, 148-155.
LeMaistre C. F., Saleh M. N., Kuzel T. M., Foss F., Platanias L. C., Schwartz G., Ratain M., Rook A., Freytes C. O., Craig F. et al. (1998) Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. Blood 91, 399-405.
Leonard Warren (1959). The thiobarbituric acid assay of sialic acids. J Biol Chem. 234, 1971-1975
Leuven F. V., Cassiman J. J., and Berghe H. V. D. (1979). Demonstration of an α 2 -macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J. Biol. Chem. 254, 5155-5160.
Livingston B., Crimi C., Newman M., Higashimoto Y., Appella E., Sidney J., and Sette A. (2002) A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes. The Journal of Immunology 168, 5499–5506.
Mandal, M., Dudkin, V. Y., Geng, X. D. & Danishefsky, S. (2004). In pursuit of carbohydrate-based HIV vaccines, Part 1: The total synthesis of hybrid-type gp120 fragments. Angew. Chem. 43, 2557–2561
Meezan, E., Wu, H. C., Black, P. H. & Robbins, P. W. (1969) Comparative studies on carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. Separation of glycoproteins and glycopeptides by sephadex chromatography. Biochemistry 8, 2518–2524.
Melanie L. Hart, Mohammed Saifuddin, Kazuhide Uemura, Eric G.Bremer, Brad Hooker, Toshisuke Kawasaki, and Gregory T. Spear (2002). High mannose glycans and siclic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type I. AIDS research and human retroviruses 18, 1311-1317.
Moestrup S. K., Gliemann J., and Pallesen G. (1992) Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269, 375-382.
Ota S., Ono T., Morita A., Uenaka A., Harada M., and Nakayama E. (2002) Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells. Cancer Research 62, 1471-1476.
Pai L. H., Wittes R., Setser A., Willingham M. C., Pastan I. (1996) Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med. 2, 350-353.
Pan Y, Chefalo P, Nagy N, Harding C, Guo Z. (2005). Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines. J Med Chem. 48, 875-883.
P. J., Meijer S., and Hilgers J. (2000) Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J. Clin. Oncol. 18, 574-583.
Pennington J. E. (1990) Pseudomonas aeruginosa. Vaccines and immunotherapy. Infect. Dis. Clin. North. Am. 4, 259-270.
Raval GN, Patel DD, Parekh LJ, Patel JB, Shah MH, Patel PS. (2003) Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer. Oral Dis. 9, 119-128.
Slovin SF, Keding SJ, Ragupathi G. (2005) Carbohydrate vaccines as immunotherapy for caner. Immunol Cell Biol. 83, 418-428
Skoza L. and Mohos S. (1976) Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Biochem. J. 159, 457-462.
Turner, G. A. (1992) N-Glycosylation of serum-proteins in disease and its investigation using lectins. Clin. Chim. Acta 208, 149–171.
Von Mensdorff-Pouilly S., Verstraeten A. A., Kenemans P., Snijdewint F. G. M., Kok A., Van Kamp G. J., Paul M. A., Van Diest P. J., Meijer S., and Hilgers J. (2000) Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J. Clin. Oncol. 18, 574-583.
Zhang, S. L. et al. (1997) Selection of tumor antigens as targets for immune attack using immunohistochemistry. 1. Focus on gangliosides. Int. J. Cancer 73, 42-49.
Zhang, S. L. et al. (1997) Selection of tumor antigens as targets for immune attack using immunohistochemistry. 2. Blood group–related antigens. Int. J. Cancer 73, 50-56.
|